136 related articles for article (PubMed ID: 36989579)
1. Incidence and risk factors of unanticipated pathology in cases of hysterectomy for benign lesion a cross-section study in Al Shifa Medical Complex.
AbuSaqer SM; Shammala AIHA; Elejla S; Mahdi H; Laban RA; Hamada HA; Zimmo MW
Cancer Treat Res Commun; 2023; 35():100697. PubMed ID: 36989579
[TBL] [Abstract][Full Text] [Related]
2. Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse.
Frick AC; Walters MD; Larkin KS; Barber MD
Am J Obstet Gynecol; 2010 May; 202(5):507.e1-4. PubMed ID: 20452498
[TBL] [Abstract][Full Text] [Related]
3. The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications.
Yildiz G; Mat E; Yildiz P; Gundogdu EC; Basol G; Kurt D; Kale A
J Obstet Gynaecol; 2021 Feb; 41(2):298-304. PubMed ID: 33448228
[TBL] [Abstract][Full Text] [Related]
4. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications.
Mahnert N; Morgan D; Campbell D; Johnston C; As-Sanie S
Obstet Gynecol; 2015 Feb; 125(2):397-405. PubMed ID: 25569001
[TBL] [Abstract][Full Text] [Related]
5. Adenomyosis among samples from hysterectomy due to abnormal uterine bleeding.
Pervez SN; Javed K
J Ayub Med Coll Abbottabad; 2013; 25(1-2):68-70. PubMed ID: 25098058
[TBL] [Abstract][Full Text] [Related]
6. Incidence of occult malignancies identified during hysterectomies performed for benign indications.
Topdagi Yilmaz EP; Cimilli Senocak GN; Topdagi YE; Aynaoglu Yildiz G; Kumtepe Y
J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101620. PubMed ID: 31449888
[TBL] [Abstract][Full Text] [Related]
7. Adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding associated with uterine leiomyomas.
Lonky NM; Chiu V; Portugal C; Estrada EL; Chang J; Fischer H; Vora JB; Harrison LI; Peng L; Munro MG
PLoS One; 2023; 18(12):e0294925. PubMed ID: 38079406
[TBL] [Abstract][Full Text] [Related]
8. The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications.
Ding Y; Han Y; Zhang S; Shi X
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4339-4345. PubMed ID: 36083311
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3).
Heremans R; Van Den Bosch T; Valentin L; Wynants L; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Leone FPG;
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):243-255. PubMed ID: 35385178
[TBL] [Abstract][Full Text] [Related]
10. The Value of Adenomyosis Type in Clinical Assessment: A Single-center Experience of 755 Nodular and Diffuse Adenomyosis Cases.
Selvi Demirtas G; Uyar I
Arch Iran Med; 2021 May; 24(5):374-382. PubMed ID: 34196202
[TBL] [Abstract][Full Text] [Related]
11. Endometrial ablation in the management of abnormal uterine bleeding.
Laberge P; Leyland N; Murji A; Fortin C; Martyn P; Vilos G; ; Leyland N; Wolfman W; Allaire C; Awadalla A; Dunn S; Heywood M; Lemyre M; Marcoux V; Potestio F; Rittenberg D; Singh S; Yeung G;
J Obstet Gynaecol Can; 2015 Apr; 37(4):362-79. PubMed ID: 26001691
[TBL] [Abstract][Full Text] [Related]
12. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
13. Hysterectomy and Oophorectomy in Reproductive Age: A Cross-Sectional Study from a Tertiary Care Hospital.
Shahid R; Abbas H; Mumtaz S; Perveen F; Bari MF; Raja T; Memon S; Ahmed N; Dawani K
Cureus; 2020 May; 12(5):e8344. PubMed ID: 32617218
[TBL] [Abstract][Full Text] [Related]
14. [Surgical hysteroscopy or hysterectomy in the treatment of benign uterine lesions. What to choose in 1998?].
Herman P; Gaspard U; Foidart JM
Rev Med Liege; 1998 Dec; 53(12):756-61. PubMed ID: 9927874
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
Parsons LHP; Pedersen R; Richardson DL; Kho KA
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():108-112. PubMed ID: 29518640
[TBL] [Abstract][Full Text] [Related]
16. Rates of unanticipated premalignant and malignant lesions at the time of hysterectomy performed for pelvic organ prolapse in an underscreened population.
Barakzai S; Koltun-Baker E; Melville SJF; Rangel E; Dahl M; Dancz CE
AJOG Glob Rep; 2023 May; 3(2):100217. PubMed ID: 37275440
[TBL] [Abstract][Full Text] [Related]
17. Histopathology diagnosis in women who underwent a hysterectomy for a benign condition.
Saleh SS; Fram K
Arch Gynecol Obstet; 2012 May; 285(5):1339-43. PubMed ID: 22124533
[TBL] [Abstract][Full Text] [Related]
18. Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases.
Rechberger T; Miotła P; Futyma K; Ziętek A; Filipczak A; Rechberger E; Szumiło J; Adamiak-Godlewska A
Ginekol Pol; 2016; 87(8):546-51. PubMed ID: 27629127
[TBL] [Abstract][Full Text] [Related]
19. Hysterectomy in women with cervical stenosis. Surgical indications and pathology.
Newman C; Finan MA
J Reprod Med; 2003 Sep; 48(9):672-6. PubMed ID: 14562629
[TBL] [Abstract][Full Text] [Related]
20. Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative.
Corona LE; Swenson CW; Sheetz KH; Shelby G; Berger MB; Pearlman MD; Campbell DA; DeLancey JO; Morgan DM
Am J Obstet Gynecol; 2015 Mar; 212(3):304.e1-7. PubMed ID: 25542564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]